Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking fluticasone furoate for the treatment of mild-to-moderate COVID-19 symptoms.
Monoclonal Antibody Treatment Reduced Deaths in Hospitalized COVID Patients
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.
Meet Gerald Grant, MD, Chair of the Duke Department of Neurosurgery
A rich background -- which included time in the US Air Force and Iraq and as an endowed professor, associated dean, and chief of pediatric neurosurgery at Stanford University-- contributed to the making of Grant into an outstanding leader poised to take Duke Neurosurgery to new and exciting directions.
Real-time Imaging Helps Women Avoid Repeat Surgery After Lumpectomy
A Duke University School of Medicine study shows the potential of new imaging technology to change the landscape of breast cancer surgery.
Barbara Sheline Starts a New Chapter After 32 Years at Duke
Barbara Sheline, MD, MPH, who has directed the Primary Care Leadership Track (PCLT) program in the Duke University School of Medicine since its establishment in 2011, retired on June 30, 2022.
Fish Oil Appears to Ease Post-Operative Delirium in Pre-Clinical Studies
Fish oil triglycerides appear to be effective at reducing instances of inflammation in the brain and preventing post-surgical delirium in mice and tissue engineered human models, according to Duke Health and Duke Biomedical Engineering researchers.
Role Identified for Key Gene in Developmental Disability Syndrome
A single gene that was previously found to be the driving force in a rare syndrome linked to epilepsy, autism and developmental disability has been identified as a linchpin in the formation of healthy neurons.
Congratulations to the 2022 LEADER Alumni!
The Leadership Development for Researchers (LEADER) Program is designed for junior faculty who are leading a research group and driving their own research agenda.
CTSI Makes MURDOCK Biorepository Samples, Data Available to Researchers
The Duke Clinical and Translational Science Institute (CTSI) has announced a new opportunity for Duke investigators to obtain biospecimens from the MURDOCK Study for research. The MURDOCK study is a landmark longitudinal cohort of more than 12,000 diverse participants linked to clinical data and up to 14 years of outcomes data.
Creating a Sense of Community for LGBTQ Students
DukeMed Pride offers LGBTQ students in the School of Medicine a space to find mentors, networking, and a sense of community.